Kanabo Group (LON:KNB) Hits New 12-Month Low – Should You Sell?

Kanabo Group Plc (LON:KNB) shares hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 0.90 ($0.01) and last traded at GBX 1.20 ($0.02), with a volume of 143689 shares changing hands. The stock had previously closed at GBX 1.06 ($0.01).

Kanabo Group Price Performance

The company has a fifty day simple moving average of GBX 1.16 and a two-hundred day simple moving average of GBX 1.37. The company has a debt-to-equity ratio of 3.49, a quick ratio of 24.36 and a current ratio of 2.78. The company has a market capitalization of £7.59 million, a price-to-earnings ratio of -120.00 and a beta of 3.04.

Insider Transactions at Kanabo Group

In related news, insider Ian Mattioli bought 150,000 shares of the business’s stock in a transaction on Tuesday, August 27th. The shares were bought at an average cost of GBX 1 ($0.01) per share, for a total transaction of £1,500 ($1,952.62). Corporate insiders own 37.01% of the company’s stock.

Kanabo Group Company Profile

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.